Recombinant E.coli IFNt Protein，His

Interferon Tau (IFNt) is a type I interferon predominantly produced by the trophectoderm of ruminant embryos during early pregnancy. Its primary role is to signal maternal recognition of pregnancy, ensuring that the maternal immune system does not reject the developing embryo. Research on IFNt has gained significant attention due to its potential applications in reproductive biotechnology and veterinary medicine. Scientists have been particularly focused on the recombinant production of IFNt, as it allows for the study of its biological functions and mechanisms in a controlled environment. This recombinant protein can be utilized in various experimental settings to investigate its effects on immune modulation, cell signaling pathways, and its role in sustaining early pregnancy. Additionally, advances in cloning and protein engineering techniques have facilitated the development of optimized IFNt variants with enhanced biological activity. These studies not only deepen our understanding of early gestation in ruminants but also open doors for innovative approaches in fertility treatments and hormonal therapies in livestock and possibly in human medicine. The ongoing research aims to elucidate the multifaceted roles of IFNt in reproductive health, paving the way for developing novel reproductive technologies and improving reproductive outcomes in both agricultural and clinical settings.